<code id='51BE79F473'></code><style id='51BE79F473'></style>
    • <acronym id='51BE79F473'></acronym>
      <center id='51BE79F473'><center id='51BE79F473'><tfoot id='51BE79F473'></tfoot></center><abbr id='51BE79F473'><dir id='51BE79F473'><tfoot id='51BE79F473'></tfoot><noframes id='51BE79F473'>

    • <optgroup id='51BE79F473'><strike id='51BE79F473'><sup id='51BE79F473'></sup></strike><code id='51BE79F473'></code></optgroup>
        1. <b id='51BE79F473'><label id='51BE79F473'><select id='51BE79F473'><dt id='51BE79F473'><span id='51BE79F473'></span></dt></select></label></b><u id='51BE79F473'></u>
          <i id='51BE79F473'><strike id='51BE79F473'><tt id='51BE79F473'><pre id='51BE79F473'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:29321
          A person wears a headset projecting a brain -- health tech coverage from STAT
          Adobe

          Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

          With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

          advertisement

          While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          STAT Summit: How researchers deal with rejection
          STAT Summit: How researchers deal with rejection

          Fromlefttoright:BrendaCabrera-Mendoza,LaurenGhazal,andZhiYuatthe2023STATSummit.STATAttheageof26,Laur

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Why a market frenzy over new weight loss drugs defies logic

          ChristineKao/STATThere’saspecterhauntingWallStreet.Itstartedinbiotech,wherecompaniesmakingdrugsforth